The Prostate Cancer Centre, along with Hart, will be hosting its annual men’s health event from 10 a.m. until 4 p.m., ...

Scientists have reported results from an early-stage trial of an immunotherapy drug called VIR-5500. The drug offers new hope for men with advanced prostate cancer who have stopped responding to other ...

Investigators sought to determine the effect of “Smart PSA” guidelines on screening behavior and biopsy outcomes among Black men.

Researchers and clinicians from six leading medical centers and academic institutions—including the University of California San Diego—have collaborated to develop a new artificial intelligence model ...

Stage and screen actor Robert Lindsay, 76, is the 100,000th signature to the petition calling for prostate cancer screening ...

Celebrities have sent prostate cancer’s public profile soaring in recent years. But with accusations that some men are being ...

A leading professor who specialises in the research of prostate cancer has revealed the one thing all men should know and ask ...

A single PSA test at midlife may identify men with a low risk of prostate cancer for up to 20 years, supporting longer screening intervals. Men with a low baseline PSA level at midlife have a low risk ...

In a population-based cohort study, a single prostate-specific antigen (PSA) measurement in men aged 45-70 years effectively identified individuals with low risk for cancer. Men with PSA levels < 1.00 ...

Prostate cancer is the most common cancer in men, affecting around one in eight in the UK – the equivalent of 52,000 new cases a year. However, despite its prevalence, if detected early, prostate ...

Staging means finding out how far prostate cancer has spread in your body. Physicians group prostate cancers into stages I (1) through IV (4), with stage I being the least advanced and stage IV being ...